# Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

> **NCT03628651** · — · COMPLETED · sponsor: **Exact Sciences Corporation** · enrollment: 2150 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Hepatocellular Carcinoma Surveillance

## Interventions

- **OTHER:** Blood Sample Collection
- **OTHER:** Blood Sample Collection

## Key facts

- **NCT ID:** NCT03628651
- **Lead sponsor:** Exact Sciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-02
- **Primary completion:** 2020-03-11
- **Final completion:** 2020-03-11
- **Target enrollment:** 2150 (ACTUAL)
- **Last updated:** 2020-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03628651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03628651, "Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03628651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*